Statistics

Total Visits

Views
Phase I study of dasatinib in combination with trastuzumab and paclitaxel in patients with HER2 positive metastatic breast cancer37

Select a period of time:

Number of views in the range

Views
Phase I study of dasatinib in combination with trastuzumab and paclitaxel in patients with HER2 positive metastatic breast cancer27

Views

Views
May 20240
June 20242
July 20244
August 202410
September 20248
October 20242
November 20241
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States22
 

Top cities views

Views
Chicago2
Gallatin1
Prineville1